Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

DAVID M HUFFMAN

Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism

NPI
1811101256
CMS profile
82651
Location
CHATTANOOGA, TN

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$12,203.68

177 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

Page 3 of 4; records 101–150 of 177 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

DAVID M HUFFMAN

NPI 1811101256 · CMS profile ID 82651

Allopathic & Osteopathic Physicians / Internal Medicine / Endocrinology, Diabetes & Metabolism

CHATTANOOGA, TN

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 4; records 101–150 of 177 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1811101256?year=2024&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
DAVID M HUFFMAN, NPI 1811101256, CMS profile ID 82651. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 177 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1811101256?year=2024&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). DAVID M HUFFMAN, NPI 1811101256, CMS profile ID 82651. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 177 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1811101256?year=2024&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
DAVID M HUFFMAN, NPI 1811101256, CMS profile ID 82651, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 4; records 101–150 of 177 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1811101256?year=2024&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

177 matching records · $12,203.68 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 177 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 177.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Bayer Healthcare Pharmaceuticals Inc. $14.4605/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086267579 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $19.8005/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1118162918 CMS
Medtronic, Inc. $28.9105/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1119495592 CMS
Novartis Pharmaceuticals Corporation $20.8605/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086900657 CMS
Corcept Therapeutics $22.5305/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117735360 CMS
ABBVIE INC. $11.4005/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103951122 CMS
Xeris Pharmaceuticals, Inc. $10.0805/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1144591870 CMS
Novo Nordisk Inc $18.1605/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1097634016 CMS
Insulet Corporation $13.7304/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116793915 CMS
Novo Nordisk Inc $21.5304/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1096924690 CMS
Bayer Healthcare Pharmaceuticals Inc. $18.3304/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086142455 CMS
Lilly USA, LLC $23.1204/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1136126425 CMS
ABBVIE INC. $12.9204/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103951120 CMS
ABBVIE INC. $8.4504/18/2024 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104196476 CMS
Amneal Pharmaceuticals LLC $22.1104/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139189378 CMS
Novo Nordisk Inc $938.0004/17/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1097099008 CMS
PFIZER INC. $19.0404/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131322771 CMS
Bayer Healthcare Pharmaceuticals Inc. $19.1704/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086128578 CMS
Abbott Laboratories $11.7704/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125283164 CMS
Medtronic, Inc. $40.7604/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1119495588 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $15.8404/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1118162916 CMS
Novo Nordisk Inc $938.0004/04/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1097378680 CMS
Abbott Laboratories $16.5404/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125283162 CMS
SANOFI-AVENTIS U.S. LLC $21.9604/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139617380 CMS
Medtronic, Inc. $137.0704/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1119495590 CMS
Corcept Therapeutics $29.6004/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117735324 CMS
Novo Nordisk Inc $1,595.0004/01/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1097328136 CMS
Novo Nordisk Inc $938.0003/28/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1096794313 CMS
Amneal Pharmaceuticals LLC $10.5703/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139189376 CMS
Kyowa Kirin, Inc. $18.7103/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1127028345 CMS
BETA BIONICS, INC. $19.4803/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087874719 CMS
Insulet Corporation $20.1203/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116793935 CMS
ABBVIE INC. $14.9703/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103951118 CMS
Lilly USA, LLC $0.6303/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1136130674 CMS
Lilly USA, LLC $20.8703/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1136146433 CMS
Lilly USA, LLC $17.6703/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1136132934 CMS
Xeris Pharmaceuticals, Inc. $15.3003/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1144591868 CMS
Medtronic, Inc. $41.7203/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1119495586 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $15.8403/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1118162914 CMS
Novo Nordisk Inc $938.0003/06/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1097328285 CMS
Novo Nordisk Inc $19.0803/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1096598933 CMS
Amgen Inc. $20.9702/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1111603046 CMS
Medtronic, Inc. $9.9702/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1119495584 CMS
Novo Nordisk Inc $938.0002/29/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1097490122 CMS
Amneal Pharmaceuticals LLC $25.2502/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139189374 CMS
Novo Nordisk Inc $6.3702/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1096970017 CMS
Novo Nordisk Inc $938.0002/27/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1097322602 CMS
Lilly USA, LLC $20.8002/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1136156079 CMS
Mannkind Corporation $13.0702/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145843301 CMS
ABBVIE INC. $21.8002/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103951116 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $43,767.07 256
PY2020 $26,851.91 206
PY2021 $13,279.12 234
PY2022 $33,044.21 187
PY2023 $12,003.10 149
PY2024 $12,203.68 177
PY2025 $21,665.65 209

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $195,355.01 124
PY2024 Principal investigator $116,544.81 45
PY2023 Recipient $50.00 1
PY2023 Principal investigator $242,803.61 589
PY2022 Recipient $48.00 1
PY2022 Principal investigator $199,958.37 236
PY2021 Principal investigator $920,464.56 1,110
PY2020 Recipient $67,411.72 4
PY2020 Principal investigator $414,276.63 576
PY2019 Recipient $1,969.00 1
PY2019 Principal investigator $189,985.23 242

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

124 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Sequel Med Tech, LLC $488.00 12/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243757452
Principal investigator 1 Sequel Med Tech, LLC $170.80 12/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243757457
Principal investigator 1 Sequel Med Tech, LLC $488.00 12/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243757462
Principal investigator 1 Sequel Med Tech, LLC $170.80 12/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243757469
Principal investigator 1 Sequel Med Tech, LLC $488.00 12/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243757474
Principal investigator 1 Sequel Med Tech, LLC $170.80 12/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243757480
Principal investigator 1 Sequel Med Tech, LLC $2,223.00 12/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243757486
Principal investigator 1 Sequel Med Tech, LLC $778.05 12/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243757499
Principal investigator 1 Sequel Med Tech, LLC $488.00 12/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243757503
Principal investigator 1 Sequel Med Tech, LLC $170.80 12/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243757509
Principal investigator 1 Sequel Med Tech, LLC $488.00 12/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243757513
Principal investigator 1 Sequel Med Tech, LLC $170.80 12/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243757521
Principal investigator 1 Sequel Med Tech, LLC $488.00 12/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243757527
Principal investigator 1 Sequel Med Tech, LLC $170.80 12/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243757532
Principal investigator 1 Sequel Med Tech, LLC $488.00 12/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243757536
Principal investigator 1 Sequel Med Tech, LLC $170.80 12/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243757541
Principal investigator 1 Sequel Med Tech, LLC $488.00 12/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243757546
Principal investigator 1 Sequel Med Tech, LLC $170.80 12/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243757556
Principal investigator 1 Sequel Med Tech, LLC $8,000.00 12/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243757561
Principal investigator 1 Sequel Med Tech, LLC $2,800.00 12/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243757566
Principal investigator 1 Sequel Med Tech, LLC $2,223.00 12/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243757571
Principal investigator 1 Sequel Med Tech, LLC $778.05 12/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243757577
Principal investigator 1 Sequel Med Tech, LLC $488.00 12/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243757581
Principal investigator 1 Sequel Med Tech, LLC $170.80 12/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243757587
Principal investigator 1 Sequel Med Tech, LLC $488.00 12/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243757592
Principal investigator 1 Sequel Med Tech, LLC $170.80 12/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243757599
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 12/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243757604
Principal investigator 1 Sequel Med Tech, LLC $1,120.00 12/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243757618
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 12/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243757623
Principal investigator 1 Sequel Med Tech, LLC $1,120.00 12/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243757630
Principal investigator 1 Sequel Med Tech, LLC $2,223.00 12/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243757635
Principal investigator 1 Sequel Med Tech, LLC $778.05 12/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243757640
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 12/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243757648
Principal investigator 1 Sequel Med Tech, LLC $1,120.00 12/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243757653
Principal investigator 1 Sequel Med Tech, LLC $2,223.00 12/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243757660
Principal investigator 1 Sequel Med Tech, LLC $778.05 12/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243757665
Principal investigator 1 Sequel Med Tech, LLC $2,223.00 12/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243757670
Principal investigator 1 Sequel Med Tech, LLC $778.05 12/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243757680
Principal investigator 1 Sequel Med Tech, LLC $488.00 12/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243757685
Principal investigator 1 Sequel Med Tech, LLC $170.80 12/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243757690
Principal investigator 1 Sequel Med Tech, LLC $488.00 12/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243757696
Principal investigator 1 Sequel Med Tech, LLC $170.80 12/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243757701
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 12/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243757707
Principal investigator 1 Sequel Med Tech, LLC $1,120.00 12/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243757710
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 12/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243757716
Principal investigator 1 Sequel Med Tech, LLC $1,120.00 12/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243757721
Principal investigator 1 Sequel Med Tech, LLC $2,223.00 12/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243757727
Principal investigator 1 Sequel Med Tech, LLC $778.05 12/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243757738
Principal investigator 1 Novo Nordisk AS $366.57 12/22/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES AND ENDOCRINE CONSULTANTS
NN9535-4352 No dispute reported 06/30/2026 1213727684
Principal investigator 1 Sequel Med Tech, LLC $488.00 11/30/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243753614
Principal investigator 1 Sequel Med Tech, LLC $170.80 11/30/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243753620
Principal investigator 1 Sequel Med Tech, LLC $488.00 11/30/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243753626
Principal investigator 1 Sequel Med Tech, LLC $170.80 11/30/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243753632
Principal investigator 1 Sequel Med Tech, LLC $488.00 11/30/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243753637
Principal investigator 1 Sequel Med Tech, LLC $170.80 11/30/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243753644
Principal investigator 1 Sequel Med Tech, LLC $488.00 11/30/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243753650
Principal investigator 1 Sequel Med Tech, LLC $170.80 11/30/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243753654
Principal investigator 1 Sequel Med Tech, LLC $488.00 11/30/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243753661
Principal investigator 1 Sequel Med Tech, LLC $170.80 11/30/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243753667
Principal investigator 1 Sequel Med Tech, LLC $2,223.00 11/30/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243753675
Principal investigator 1 Sequel Med Tech, LLC $778.05 11/30/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243753681
Principal investigator 1 Sequel Med Tech, LLC $2,223.00 11/30/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243753687
Principal investigator 1 Sequel Med Tech, LLC $778.05 11/30/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243753693
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 11/30/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243753698
Principal investigator 1 Sequel Med Tech, LLC $1,120.00 11/30/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243753706
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 11/30/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243753713
Principal investigator 1 Sequel Med Tech, LLC $1,120.00 11/30/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243753717
Principal investigator 1 Sequel Med Tech, LLC $488.00 11/30/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243753723
Principal investigator 1 Sequel Med Tech, LLC $170.80 11/30/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243753728
Principal investigator 1 Sequel Med Tech, LLC $488.00 11/30/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243753732
Principal investigator 1 Sequel Med Tech, LLC $170.80 11/30/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243753738
Principal investigator 1 Sequel Med Tech, LLC $488.00 11/30/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243753745
Principal investigator 1 Sequel Med Tech, LLC $170.80 11/30/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243753752
Principal investigator 1 Sequel Med Tech, LLC $488.00 11/30/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243753758
Principal investigator 1 Sequel Med Tech, LLC $170.80 11/30/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243753764
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 10/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243750634
Principal investigator 1 Sequel Med Tech, LLC $1,120.00 10/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243750640
Principal investigator 1 Sequel Med Tech, LLC $1,175.00 10/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243750645
Principal investigator 1 Sequel Med Tech, LLC $411.25 10/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243750649
Principal investigator 1 Sequel Med Tech, LLC $488.00 10/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243750654
Principal investigator 1 Sequel Med Tech, LLC $170.80 10/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243750661
Principal investigator 1 Sequel Med Tech, LLC $2,223.00 10/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243750668
Principal investigator 1 Sequel Med Tech, LLC $778.05 10/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243750676
Principal investigator 1 Sequel Med Tech, LLC $488.00 10/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243750686
Principal investigator 1 Sequel Med Tech, LLC $170.80 10/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243750692
Principal investigator 1 Sequel Med Tech, LLC $488.00 10/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243750700
Principal investigator 1 Sequel Med Tech, LLC $170.80 10/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243750705
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 10/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243750709
Principal investigator 1 Sequel Med Tech, LLC $1,120.00 10/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243750713
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 10/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243750719
Principal investigator 1 Sequel Med Tech, LLC $1,120.00 10/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243750725
Principal investigator 1 Sequel Med Tech, LLC $2,223.00 10/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243750731
Principal investigator 1 Sequel Med Tech, LLC $778.05 10/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243750737
Principal investigator 1 Sequel Med Tech, LLC $2,223.00 10/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243750742
Principal investigator 1 Sequel Med Tech, LLC $778.05 10/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243750750
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 10/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243750754
Principal investigator 1 Sequel Med Tech, LLC $1,120.00 10/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243750759
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 10/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243750765
Principal investigator 1 Sequel Med Tech, LLC $1,120.00 10/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243750772
Principal investigator 1 Novo Nordisk AS $2,500.00 10/29/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES AND ENDOCRINE CONSULTANTS
NN9535-4352 No dispute reported 06/30/2026 1213754711
Principal investigator 1 Novo Nordisk AS $2,641.30 10/29/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES AND ENDOCRINE CONSULTANTS
NN9535-4352 No dispute reported 06/30/2026 1213763666
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 09/30/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243748062
Principal investigator 1 Sequel Med Tech, LLC $1,120.00 09/30/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243748066
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 09/30/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243748072
Principal investigator 1 Sequel Med Tech, LLC $1,120.00 09/30/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243748077
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 09/30/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243748083
Principal investigator 1 Sequel Med Tech, LLC $1,120.00 09/30/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243748088
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 09/30/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243748094
Principal investigator 1 Sequel Med Tech, LLC $1,120.00 09/30/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243748100
Principal investigator 1 Sequel Med Tech, LLC $3,200.00 09/30/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243748106
Principal investigator 1 Sequel Med Tech, LLC $1,120.00 09/30/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243748112
Principal investigator 1 Novo Nordisk AS $1,620.00 08/22/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES AND ENDOCRINE CONSULTANTS
NN9535-4352 No dispute reported 06/30/2026 1213728269
Principal investigator 1 Novo Nordisk AS $366.57 08/22/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES AND ENDOCRINE CONSULTANTS
NN9535-4352 No dispute reported 06/30/2026 1213760503
Principal investigator 1 Sequel Med Tech, LLC $8,000.00 07/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243745284
Principal investigator 1 Sequel Med Tech, LLC $2,800.00 07/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243745290
Principal investigator 1 Novo Nordisk AS $2,571.28 07/18/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES AND ENDOCRINE CONSULTANTS
NN9535-4352 No dispute reported 06/30/2026 1213763818
Principal investigator 1 Novo Nordisk AS $2,500.00 06/23/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES AND ENDOCRINE CONSULTANTS
EX9924-4473 No dispute reported 06/30/2026 1213829713
Principal investigator 1 Novo Nordisk AS $1,158.93 05/21/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES AND ENDOCRINE CONSULTANTS
NN9535-4352 No dispute reported 06/30/2026 1213702722
Principal investigator 1 Sequel Med Tech, LLC $4,000.00 04/30/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243743458
Principal investigator 1 Sequel Med Tech, LLC $1,400.00 04/30/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES & ENDOCRINE CONSULTANTS
Innovative Automated Insulin Delivery System for T2D No dispute reported 06/30/2026 1243743462
Principal investigator 1 Novo Nordisk AS $1,702.51 04/21/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES AND ENDOCRINE CONSULTANTS
NN9535-4352 No dispute reported 06/30/2026 1213759829
Principal investigator 1 Novo Nordisk AS $25,715.21 03/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES AND ENDOCRINE CONSULTANTS
EX9924-4473 No dispute reported 06/30/2026 1213774557
Principal investigator 1 Novo Nordisk AS $1,482.37 02/21/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES AND ENDOCRINE CONSULTANTS
NN9535-4352 No dispute reported 06/30/2026 1213776882
Principal investigator 1 Novo Nordisk AS $1,881.27 01/31/2025 Non-covered Recipient Entity
UNIVERSITY DIABETES AND ENDOCRINE CONSULTANTS
NN9535-4352 No dispute reported 06/30/2026 1213712725